DCTH DELCATH SYSTEMS, INC. Insider Trading

CFO Pennell Sandra buys 5,533 shares of DCTH at $9.04; stock now -49.8% from 52-week high

CFO Sandra Pennell purchased 5,533 shares at $9.04 on 2026-03-06, increasing her holdings by 7.7% to 77,018 shares. The buy occurs with the stock trading at $9.08, down -49.8% from its 52-week high of $18.10 and off -6.4% over the past 30 days. Fundamentally, the company shows mixed signals: FY revenue growth accelerated +129.1%, net income stands at $830,000, and the P/E ratio is 10.44, but the stock's sharp decline from highs suggests investor skepticism about near-term outlook. Pennell's prior purchase at this same ticker in November 2023 delivered strong 90-day returns (+86.0%), establishing a pattern of well-timed buys in DCTH, which provides context for evaluating whether this new purchase reflects conviction in the recent valuation reset or response to shorter-term momentum deterioration.

CEO Michel Gerard J bought 11,200 shares of DCTH at $8.96 on 2026-03-02; stock down 52.5% from 52-week high but revenue grew 129.1% YoY

MICHEL GERARD J, Chief Executive Officer, purchased 11,200 shares at $8.96, expanding his holdings by 3.4% to 342,034 shares post-transaction. The purchase occurs while DELCATH's equity is trading at $8.60, down 52.5% from its 52-week high of $18.10, placing the stock at its lowest valuation range despite fundamental momentum: annual revenue growth reached 129.1% and the company posted $20.6M quarterly revenue with $830.0K net income at a P/E of 9.89. Across his prior insider buys at DCTH (2025-11-11 and 2023-12-08), both delivered positive 90-day returns (+21.9% and +35.7% respectively), indicating a pattern of well-timed entry points at this ticker. The current purchase follows a 30-day decline of 13.2% and 90-day decline of 11.0%, positioning it similarly to his prior accumulation timing when the stock subsequently recovered.

Director Sylvester John Richard bought 4,386 shares at $8.89 (+41.6% to 14.9K holdings); stock down -49.0% from 52-week high, director's prior buy timing 0/1 well-timed.

Director Sylvester John Richard purchased 4,386 shares of DCTH at $8.89 on 2025-11-21, increasing his holdings by 41.6% from 10,550 to 14,936 shares. The stock now trades at $9.23, down 49.0% from its 52-week high of $18.10, and has declined 9.8% over the past 30 days. Critically, Richard's single prior purchase at this ticker resulted in a 90-day return of -49.0%, showing a pattern of poorly-timed entry points at DCTH. The company exhibits elevated valuation metrics (P/E of 307.67) relative to recent profitability concerns—it recorded a net loss for its most recent full fiscal year, though recent quarterly net income was $830,000 on $20.6M in revenue. The timing and price action warrant observation given the insider's historical execution at this ticker.

DCTH CEO Gerard buys 11,500 shares at $8.53; stock down -52.4% from 52-week high of $18.10

MICHEL GERARD J, Chief Executive Officer, purchased 11,500 shares at $8.53, increasing his holdings to 330,834 shares. The transaction occurs as DCTH trades at $8.61, having fallen -52.4% from its 52-week high of $18.10 and -24.3% over the past 30 days. This represents a discretionary open-market purchase by the company's top executive during a period of significant share-price deterioration. Gerard's cross-ticker buy track record shows 1 prior purchase with a 90-day return of +35.7%, and his single prior DCTH transaction (buy on 2023-12-08) also delivered a 90-day return of +35.7%. However, the company faces material headwinds: it is unprofitable on a full-year basis despite reporting quarterly revenue of $20,563,000.00 and net income of $830,000.00, and carries a P/E ratio of 287.00, reflecting minimal or unprofitable earnings. The purchase timing—amid a steep drawdown from recent highs—warrants close monitoring of whether the stock recovers as it did following his prior 2023 buy, or whether this trade signals a floor that holds in the face of underlying operational challenges.